Pharmaceutical Technology

JUNE 28, 2023

We examine the regional developments that will provide a competitive edge to pharma manufacturers. Nordic healthcare providers are leading the momentum in enhancing ESG considerations.

Pharma Meetings 130

Pharma Meetings Manufacturing Development 130

pharmaphorum

FEBRUARY 1, 2024

Explore the current state of pharmaceutical meetings and events in 2024, including the shift from in-person to virtual and hybrid formats. Discover how the industry is embracing diversity, equity, and inclusion in these gatherings.

Pharma Meetings 116

Pharma Meetings 116

BioTech 365

OCTOBER 7, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Meet Neumora, Arch’s $500M, Amgen-partnered play for the targeted future of neuroscience R&D.Meet Neumora, Arch’s $500M, Amgen-partnered play for the targeted future of neuroscience R&D ntaylor Wed, … (..)

Pharma Meetings 40

Pharma Meetings Research 40

BioTech 365

DECEMBER 9, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Meet the aquaculture industry’s new maintenance bot.This ROV can fully operate on its own, and follow along with fish’s behavior and health with its Argus eyes—all while … Continue reading →

Pharma Meetings 40

Pharma Meetings Research 40

BioTech 365

JANUARY 14, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Meet Binney Street Capital: Dana-Farber Cancer Institute’s first venture fund.Meet Binney Street Capital: Dana-Farber Cancer Institute’s first venture fund badams Thu, 01/14/2021 – 09:27 from FierceBiotech: Biotech (..)

Pharma Meetings 40

Pharma Meetings Research 40

pharmaphorum

SEPTEMBER 23, 2021

As the world passes the year and a half mark of the COVID-19 pandemic, the evolving ‘new normal’ experience across the healthcare sector has brought huge changes to the way pharma engages healthcare professionals.

Pharma Meetings 98

Pharma Meetings Development 98

pharmaphorum

JUNE 26, 2018

There has been a myriad of reasons over the past few years to safely assume the popularity and perceived worth of face-to-face medical meetings was well and truly on the decline – from advances in technology, to funding challenges.

Cardiology 52

Cardiology Pharma Meetings Research 52